Opendata, web and dolomites

LiVirIn

3D Liver Organoids: Modelling Host Hepatitis B Virus Interaction

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LiVirIn project word cloud

Explore the words cloud of the LiVirIn project. It provides you a very rough idea of what is the project "LiVirIn" about.

disseminated    hepatic    industries    endothelial    reactivation    tropism    mobility    culture    antiviral    boost    hscs    ing    hypothesize    organoids    stellate    dna    human    carrier    closed    replication    inter    superior    disease    400    chemotherapy    prevented    vitro    clinically    narrow    stem    presentations    an    pscs    viral    model    matrix    pluripotent    pharmaceutical    suppression    thinker    conferences    researcher    delivers    knowledgeable    hepatitis    animal    biology    658    stable    scientific    cells    international    circular    3d    publications    lost    infection    engineering    hampered    expertise    life    cccdna    meetings    hepatocytes    enormous    immune    models    function    safe    worldwide    train    drugs    nucleus    form    biophysical    maturation    million    biophysics    lsecs    sinusoidal    academia    completely    lack    wages    appropriate    people    industry    eradicate    particles    mimics    inexhaustible    networking    biochemical    creation    independent    risk    liver    hbv    chronically    hepatocyte    annually    virus    source    infected    vaccination    causing    cure    strategies    covalently    efficacy    encompassing    hypothesis    interdisciplinary    peer    evaluation    medical    transfer    potent   

Project "LiVirIn" data sheet

The following table provides information about the project.

Coordinator
KATHOLIEKE UNIVERSITEIT LEUVEN 

Organization address
address: OUDE MARKT 13
city: LEUVEN
postcode: 3000
website: www.kuleuven.be

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Project website http://www.kuleuven.be/samenwerking/scil/about_us/livirin
 Total cost 172˙800 €
 EC max contribution 172˙800 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2014
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2015
 Duration (year-month-day) from 2015-03-01   to  2017-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KATHOLIEKE UNIVERSITEIT LEUVEN BE (LEUVEN) coordinator 172˙800.00

Map

 Project objective

An estimated ~400 million people are chronically infected with hepatitis B virus (HBV) infection worldwide, resulting in an estimated $658 million in medical costs and lost wages annually. Although HBV disease can be prevented by vaccination, many people still become infected. Potent and safe drugs are available to eradicate HBV viral particles and clinically ‘cure’ HBV infection. However, during replication HBV delivers a very stable form of viral DNA (covalently closed circular DNA, cccDNA) in the nucleus of the hepatocyte, causing life-long risk of reactivation of HBV infection in case of suppression of the immune system (e.g. chemotherapy). Therefore the pharmaceutical industry is now aiming to develop strategies to eradicate the virus from the infected liver completely. Such studies are hampered by the lack of appropriate in vitro or animal models due to the narrow tropism of HBV for human hepatocytes. The hypothesis of the project is that creation of 3D culture systems encompassing hepatocytes, hepatic stellate cells (HSCs) and liver sinusoidal endothelial cells (LSECs) derived from an inexhaustible source of cells (human pluripotent stem cells (PSCs)) in a matrix that mimics the biophysical and biochemical features of the liver, will be a superior model for the study of HBV infection and evaluation of the efficacy of antiviral drugs. We also hypothesize that such 3D organoids will improve maturation and function of hepatocytes, HSCs and LSECs. The proposed studies are highly interdisciplinary, merging expertise from biology, to biophysics and engineering, with inter-sector mobility, networking, collaboration and knowledge transfer between academia and industries. The knowledge developed will be disseminated by presentations at consortium meetings, international conferences and in peer publications. All these aspects will train the researcher as independent thinker, more knowledgeable in scientific research which will provide an enormous boost to his carrier.

 Publications

year authors and title journal last update
List of publications.
2016 M. Kumar, G. Rustandi, R. Boon, R. S. Patil, P. Roelandt, C. Verfaillie;
2016 TERMIS - Americas Conference and Exhibition San Diego, CA December 11–14, 2016
published pages: S-1-S-156, ISSN: 1937-3341, DOI: 10.1089/ten.tea.2016.5000.abstracts
Tissue Engineering Part A 22/S1 2019-07-24

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LIVIRIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LIVIRIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

Widow Spider Mating (2020)

Immature mating as a novel tactic of an invasive widow spider

Read More  

TARGET SLEEP (2020)

Boosting motor learning through sleep and targeted memory reactivation in ageing and Parkinson’s disease

Read More  

ASIQS (2019)

Antiferromagnetic spintronics investigated by quantum sensing techniques

Read More